Amgen Inc. announced that its blood cancer drug was capable of extending the lives of patients suffering from multiple myeloma.
A new study found that an Amgen drug was effective in treating symptoms of an allergic asthma attack.
Amgen's cholesterol drug was successful in lowering LDL cholesterol after one year.
For the first time, the use of a virus to kill cancer has succeeded in a late-stage clinical trial.
The Food and Drug Administration stopped the drug trial of Sensipar after the death of a 14 year-old patient.